-
-
Call more information
660-596-2224 -
The US Food and Drug Administration (FDA) has approved an injectable form of dantrolene sodium (Ryanodex, Eagle Pharmaceuticals) for rapid treatment of malignant hyperthermia (MH), along with the appropriate supportive measures, the company announced in a news release. MH is a potentially fatal inherited disorder triggered by exposure to certain drugs used for general anesthesia, […]
Read MoreLumbar surgery is effective 12 months after in all but 13.8% of patients—a statistic obtained, along with predictors of poor outcome, from the National Neurosurgery Quality and Outcomes Database (N2QOD), a two-year-old, nationwide, prospective, longitudinal outcomes registry that spans 43 sites. For this study, N2QOD provided data on 12-month surgical outcomes for patients with lumbar […]
Read MoreSometimes, when negatives seem to outweigh the positives for your budding business, you feel like you’ll never crawl out of your rut. What’s the best way to push forward? Face the problem head on. Here are five ways to take action on your problems today: 1. Set smaller goals You’re capable of conceiving incredible, detailed […]
Read MoreAuthors: P. E. Marik, J. Lemson Published in Br J Anaesth. 2014;112(4):617-620. Decisions regarding fluid therapy, whether this be in the operating theatre (OT), intensive care unit (ICU), emergency department (ED), or general ward, are among the most challenging and important tasks that clinicians face on a daily basis. Specifically, almost all clinicians would agree […]
Read MoreMost hospital administrators do not understand anesthesia economics very well, so convincing them of the need for financial support is an uphill battle. Unfortunately at the same time anesthesia groups often do not have a very good handle on their own financial situation. The two sides enter negotiations with very different ideas about the level […]
Read More